$17.6M
1 filing since 2025 · latest Debt filed
CardioMech AS is a Norwegian medical device company dedicated to innovating minimally invasive solutions for structural heart disease, particularly degenerative mitral regurgitation (DMR). With a focus on transforming patient care, the company aims to provide effective alternatives to traditional surgery for this common and serious heart condition.
What sets it apart
CardioMech AS is distinguished by its development of catheter-based devices that simplify the repair of mitral valve dysfunction without the need for open-heart surgery.
The CardioMech device functions as an artificial chord for transcatheter mitral valve chordal repair. It is designed to be delivered through a minimally invasive, transfemoral, transseptal approach, allowing for ease of insertion and minimal recovery time.
